Farms.com Home   News

US meat eaters driven by health, not eco concerns

Nov 12, 2024
By Farms.com

Rutgers finds health tops sustainability in meat choices

Recent findings from Rutgers University indicate that environmental sustainability has minimal influence on Americans' meat consumption decisions.

The study, involving more than 1,200 adults, suggests that health concerns and price significantly outweigh environmental considerations.

According to the research, published in Appetite, 78% of respondents consume red meat weekly, but nearly 70% have reduced their intake primarily for health (64%) and price (32%) reasons, with only a small fraction (6%) motivated by environmental concerns. 

The study also revealed that health (85%) and taste (84%) are the most crucial factors for consumers when purchasing meat, compared to environmental sustainability (29%) and animal welfare (28%).

Notably, demographic trends show that older adults and females are more inclined to consider health and environmental impacts in their dietary choices.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.